Will a twist of viral fate lead to a new cancer treatment?
Pennisi
E
E
D017501:Adenovirus E1B Proteins / Q000235:genetics* / Q000378:metabolism; D000260:Adenoviruses, Human / Q000235:genetics / Q000502:physiology*; D000818:Animals; D017321:Clinical Trials, Phase I as Topic; D003588:Cytopathogenic Effect, Viral; D005814:Genes, Viral; D016158:Genes, p53; D006258:Head and Neck Neoplasms / Q000628:therapy* / Q000821:virology; D006801:Humans; D051379:Mice; D009154:Mutation; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000628:therapy* / Q000821:virology; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism; D014779:Virus Replication
D017501:Adenovirus E1B Proteins; D016159:Tumor Suppressor Protein p53